Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.
Biossil has raised $70.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Biossil's investors include OpenAI, Founders Fund, Quiet Capital, 137 Ventures, Panache Ventures.
Biossil is headquartered in Toronto, Canada.
Biossil is an applied AI drug discovery platform to create specialized treatments for distinct patients.
Biossil is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biossil — Funding & Investors." VCBacked, April 23, 2026, https://www.vcbacked.co/company/biossil. Accessed August 14, 2026.
VCBacked. (2026). Biossil — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/biossil
{{cite web |title=Biossil — Funding & Investors |url=https://www.vcbacked.co/company/biossil |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated